Tag:
Xencor
Latest Headlines
Latest Headlines
Amgen licenses Xencor's early-stage autoimmune drug
Amgen has secured the option to co-develop Xencor's preclinical autoimmune drug XmAb5871, which targets CD19 and CD32b. Xencor gains undisclosed upfront and milestone payments for early development
HGS, Xencor team up on antibody tech
In another display of monoclonal antibodies' appeal to drug developers, Maryland-based Humab Genome Sciences announced that it will team up with Xencor on drug development. Xencor uses its XmAb
Xencor adds $15M to fifth VC round
Oxford Bioscience Partners and Merlin Nexus joined Novo Nordisk in pumping $15 million more into Xencor's Series E, bringing the grand total to $60 million. Xencor is developing new therapies for
